Ummc Msgcc is a clinical research site located in Baltimore, Maryland, United States 21201.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Ummc Msgcc has participated in 12 clinical trials.
Therapeutic areas: Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV), Rectal Adenocarcinoma, RECURRENT GLIOBLASTOMA.
Sponsors: University of Maryland, Baltimore.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Ummc Msgcc has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Ummc Msgcc has 12 clinical trials on record. Their work covers Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV), Rectal Adenocarcinoma, RECURRENT GLIOBLASTOMA.
Yes — Ummc Msgcc holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.